{"id":193820,"name":"BAVARIAN NORDIC INC.","slug":"bavarian-nordic-inc","state":"DC","country":"United States of America","description":"Biotechnology pharmaceutical product discovery and development.","totalSpending":1635000,"filings":34,"yearlySpending":[{"year":2018,"income":180000},{"year":2019,"income":180000},{"year":2020,"income":180000},{"year":2021,"income":180000},{"year":2022,"income":270000},{"year":2023,"income":180000},{"year":2024,"income":225000},{"year":2025,"income":240000}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["EAST END GROUP, LLC"],"lobbyists":["MICHAEL WOODY","ANDREW HAWKINS","DAVID MOHLER","KELLY CHILDRESS LANGE"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; Departments of Labor, Health and Human Services, and","General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and","General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and","General health care coverage and reimbursement for prescription drugs; Regulatory issues related to biodefense vaccine development and procurement; H.R. 6378, Pandemic and All-Hazards Preparedness and","The re-authorization of the Pandemic and All-Hazards Preparedness Act. Funding for the Biomedical Advanced Research and Development Authority in the LHHS Appropriations bill."]}